LUNG vs VNO · rev $43.3M vs rev $921.3M
Pulmonx Corp (LUNG) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Pulmonx Corp (LUNG) is a medical devices company listed on US.
VNO (VNO) common stock.
Latest reported LUNG revenue for 2026-06-30 was $43.3M. Net income was -$23.7M. LUNG currently screens at market cap $111.9M.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
LUNG currently screens at market cap $111.9M. VNO currently screens at market cap $0.
Not investment advice. Open the LUNG and VNO stock pages for the full models.
Not investment advice.